$93.5 Million is the total value of Atlas Venture Associates IX, LLC's 7 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
NTLA | INTELLIA THERAPEUTICS INC | $26,443,000 | -4.2% | 1,615,321 | 0.0% | 28.28% | +9.1% | |
SYBX | SYNLOGIC INC | $24,133,000 | +19.9% | 2,651,963 | 0.0% | 25.81% | +36.5% | |
SPRO | SPERO THERAPEUTICS INC | $15,849,000 | -10.1% | 1,376,968 | 0.0% | 16.95% | +2.3% | |
SURF | SURFACE ONCOLOGY INC | $13,100,000 | -40.9% | 4,645,453 | 0.0% | 14.01% | -32.7% | |
UMRX | UNUM THERAPEUTICS INC | $8,807,000 | -40.3% | 3,361,535 | 0.0% | 9.42% | -32.1% | |
CBLK | CARBON BLACK INC | $3,031,000 | +19.8% | 181,273 | 0.0% | 3.24% | +36.4% | |
SNAP | SNAP INCcl a | $2,147,000 | +29.7% | 150,160 | 0.0% | 2.30% | +47.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-06
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
INTELLIA THERAPEUTICS INC | 28 | Q3 2023 | 100.0% |
SNAP INC | 26 | Q3 2023 | 11.4% |
SPERO THERAPEUTICS INC | 24 | Q3 2023 | 24.0% |
SYNLOGIC INC | 24 | Q2 2023 | 35.6% |
SURFACE ONCOLOGY INC | 21 | Q2 2023 | 33.3% |
SKILLZ INC | 12 | Q3 2023 | 87.5% |
UNUM THERAPEUTICS INC | 11 | Q3 2020 | 28.2% |
COGENT BIOSCIENCES INC | 7 | Q2 2022 | 9.6% |
CARBON BLACK INC | 6 | Q3 2019 | 7.8% |
COHERUS BIOSCIENCES INC | 1 | Q3 2023 | 18.1% |
View Atlas Venture Associates IX, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-11-13 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-08 |
13F-HR | 2023-01-31 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-11 |
13F-HR | 2022-05-12 |
13F-HR | 2022-01-27 |
13F-HR | 2021-11-04 |
13F-HR | 2021-08-11 |
View Atlas Venture Associates IX, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.